1. Medtech Insight

Expert Panel Discusses Trends In Digital Health Investment

 
• By Marion Webb

An expert panel at the AdvaMed MedTech Conference in San Francisco discussed trends in digital health investment including market opportunities and regulatory and reimbursement challenges.

MT1905_digital-heart-pulse_215103778_1200_001.jpg

Digital health still sparks excitement, but also a healthy dose of caution. That was among the messages shared by an expert panel at the AdvaMed MedTech Conference in San Francisco. Panelists, comprising Wall Street analysts, VC investors and research groups, discussed digital investment trends, regulatory and reimbursement challenges, and opportunities in this space, as well as offered advice for start-ups.

Bill Evans, managing director at Rock Health, a venture fund that tracks investment in US start-ups, said that after investors poured nearly a record $8.1bn in the digital health...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Digital Technologies

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.